An Update on Neurofibromatosis Type 1

An Update on Neurofibromatosis Type 1


ICNTN Webinar
  • Dr. Verushka Ramanjam
October 14, 2023
CPD/CME Credits

This content is only available for our subscribers. Please click here to subscribe to a subscription plan for unrestricted access.

Topic: An Update on Neurofibromatosis Type 1;

Talk By: Dr. Verushka Ramanjam;

When: October 14, 2023, at 9:00 AM Eastern Time ( US / Canada ).

Click Here to join the session. 

Dr Ramanjam is a Neuro-Developmental Paediatrician working at 2 Military Hospital and, Red Cross Children’s Hospital, and the University of Cape Town, South Africa. She is a full-time clinician and undergraduate and postgraduate teacher who manages a range of Neurological and Developmental Disorders, including Autism, Cerebral Palsy, ADHD, Epilepsy, Learning Disability, Genetic Disorders, and many others. Dr Ramanjam is one of the founding members of the multidisciplinary Neurofibromatosis clinic at Red Cross War Memorial Hospital in 2003, where she has focussed her research. She is an executive member of the Paediatric Neurology and Developmental Association of South Africa (PANDA) and is on the 18th International Child Neurology Conference (ICNC) 2024 scientific program committee.


This talk will provide an update on the revised diagnostic criteria for NF1 and an overview of the main complications. There will be a review of the literature with regard to surveillance, screening, management, and challenges faced in the care of children with Neurofibromatosis 1. Special emphasis will be placed on the management of Plexiform Neurofibromas with MEK inhibitors, as well as the treatment challenges in resource-limited settings. Case vignettes of patients seen at the Red Cross Children’s Hospital Neurofibromatosis clinic will be included. There will be a review of the Neuro-cognitive profiles of children with NF1. Observations and lessons from the multidisciplinary service at Red Cross Children’s Hospital over the past 20 years will be reflected upon.


By attending this session, you will be able to learn about the following points:

  • An update on the new diagnostic criteria and differential diagnoses of Neurofibromatosis 1.
  • Guidelines for screening, investigating, and managing Plexiform Neurofibromas, Optic Gliomas, and other Malignant lesions associated with NF1.
  • An overview of the Psycho-social impact of NF1.
  • Reflections from the service at Red Cross Children’s Hospital regarding surveillance, management, and transition of care.

Click Here to join the session.

Viewer Review

No viewer reviews
Already have an account? or Create an account